World Trade Organization meeting this week to discuss proposed extension of TRIPS transition period for LDCs

NewsGuard 100/100 Score

"On March 5-6, the Trade-Related Aspects of Intellectual Property Rights Council of the World Trade Organization will meet in Geneva to seal the fate of the proposal lengthening the TRIPS transition period for the 49 least-developed countries [LDCs]," Devex's "The Development Newswire" reports, noting, "The transition period, set to expire July 2013, exempts LDCs from the terms of the TRIPS agreement on patents and test data protection for pharmaceuticals." According to the news service, "The Joint U.N. Program on HIV/AIDS [UNAIDS] and U.N. Development Program [UNDP] [last] week backed the proposal by releasing a new brief that urges WTO members to mull the health, economic and development benefits of an extension."

"In the brief, UNAIDS and UNDP said the transition period must be extended since LDCs continue to have special needs and requirements for social and economic development," Devex notes, adding, "Failure to extend the transition period, they added, could block LDCs' access to vital life-saving antiretroviral treatment and other medicines." The news service writes, "Other groups have voiced their support for the proposal," noting, "A recent letter signed by 376 international networks and organizations demanded that the TRIPS Council unconditionally give LDCs a transition period until the time that they have ceased to become underdeveloped" (Morden, 3/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.